Mar Cabeza-Cabrerizo
- Immunology top 1%
- Immunotherapy and Immune Responses 5
- T-cell and B-cell Immunology 3
- Immune cells in cancer 2
- Immune Cell Function and Interaction 2
- interferon and immune responses 1
- Oncology top 5%
-
- vaccines and immunoinformatics approaches 1
- Signaling Pathways in Disease 1
- Rehabilitation top 10%
-
- COVID-19 epidemiological studies 1
- Co-authors
- Caetano Reis e SousaNeil C. RogersErik SahaiProbir ChakravartyJan P. BöttcherH. BleesSantiago ZelenayEduardo Bonavita
- Cited by
- ImmunologyOncologyCancer Research
- Partner nations
- United KingdomGermanyUnited States
In The Last Decade
Mar Cabeza-Cabrerizo
9 papers receiving 2.3k citations
Hit Papers
Peers
Comparison fields: 5 of 101
- Immunology 1.7k
- Oncology 921
- Cancer Research 158
- Molecular Biology 522
- Rehabilitation 47
Countries citing papers authored by Mar Cabeza-Cabrerizo
This map shows the geographic impact of Mar Cabeza-Cabrerizo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mar Cabeza-Cabrerizo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mar Cabeza-Cabrerizo more than expected).
Fields of papers citing papers by Mar Cabeza-Cabrerizo
This network shows the impact of papers produced by Mar Cabeza-Cabrerizo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mar Cabeza-Cabrerizo. The network helps show where Mar Cabeza-Cabrerizo may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Mar Cabeza-Cabrerizo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 7 | |
| 2 | 2023 | 5 | |
| 3 | 2022 | 17 | |
| 4 | 2021 | 31 | |
| 5 | Dendritic Cells Revisitedbreakdown → | 2021 | 470 |
| 6 | 2019 | 78 | |
| 7 | NK Cells Stimulate Recruitment of cDC1 into the Tumor Microenvironment Promoting Cancer Immune Controlbreakdown → | 2018 | 1313 |
| 8 | Macrophage function in tissue repair and remodeling requires IL-4 or IL-13 with apoptotic cellsbreakdown → | 2017 | 401 |
| 9 | 2016 | 17 |
About Mar Cabeza-Cabrerizo
Mar Cabeza-Cabrerizo is a scholar working on Immunology, Modeling and Simulation and Oncology, having authored 9 papers that have together received 2.3k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (5 papers), T-cell and B-cell Immunology (3 papers), Immune cells in cancer (2 papers), Immune Cell Function and Interaction (2 papers), vaccines and immunoinformatics approaches (1 paper), interferon and immune responses (1 paper), COVID-19 epidemiological studies (1 paper) and Signaling Pathways in Disease (1 paper). The work is most often cited by research in Immunology (1.7k citations), Oncology (921 citations) and Cancer Research (158 citations). Mar Cabeza-Cabrerizo has collaborated with scholars based in United Kingdom, Germany and United States. Frequent co-authors include Caetano Reis e Sousa, Neil C. Rogers, Erik Sahai, Probir Chakravarty, Jan P. Böttcher, H. Blees, Santiago Zelenay, Eduardo Bonavita, Stefano Sammicheli and Carlos M. Minutti. Their work appears in journals such as Science, Cell and Journal of the American Chemical Society.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.